AFYA LTD-CLASS A (NASDAQ:AFYA): A Caviar Cruise Quality Screen Standout
Reported earlier, Afya Affirms FY2026 Sales Guidance of $731.710M-$759.496M vs $760.310M Est
Reported Earlier, Afya Q1 EPS $0.55 Beats $0.54 Estimate, Sales $192.330M Beat $191.870M Estimate
Afya Limited (AFYA) Q1 2026 Earnings Call Transcript
Afya Limited 2026 Q1 - Results - Earnings Call Presentation
JP Morgan Maintains Neutral on Afya, Lowers Price Target to $21.5
Afya Ltd (NASDAQ:AFYA) Passes the Quality Investing "Caviar Cruise" Screen
Insider Selling: Virgilio Deloy Capobianco Gibbon Unloads $323K Of Afya Stock
Afya Limited 2025 Q4 - Results - Earnings Call Presentation
Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
Reported earlier, Afya Sees FY2026 Sales $731.710M-$759.496M vs $763.950M Est
Afya Q4 Adj. EPS $0.42 Beats $0.37 Estimate, Sales $169.130M Miss $177.120M Estimate
B of A Securities Downgrades Afya to Neutral, Lowers Price Target to $17
Lincoln Educational Services Corporation (LINC) Beats Q4 Earnings and Revenue Estimates
Deep Dive Into Afya Stock: Analyst Perspectives (4 Ratings)
Morgan Stanley Downgrades Afya to Underweight, Lowers Price Target to $16
Afya Limited Announces Medical Seats Increase in Afya Abaetetuba
Afya (NASDAQ:AFYA) Is Doing The Right Things To Multiply Its Share Price
UBS Sees Higher Spending Weighing on Afya Limited (AFYA)’s Near-Term Outlook
UBS Downgrades Afya to Neutral, Lowers Price Target to $16
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.